Highly Expressed Genes in Pancreatic Ductal Adenocarcinomas: A Comprehensive Characterization and Comparison of the Transcription Profiles Obtained from Three Major Technologies

Cancer Research

Volumn 63, Issue 24, 2003, Pages 8614-8622

  Iacobuzio Donahue, Christine A ^a,f   Ashfaq, Raheela ^b   Maitra, Anirban ^a   Adsay, N Volkan ^c   Shen Ong, Grace L ^d   Berg, Karin ^a   Hollingsworth, Michael A ^e   Cameron, John L ^a   Yeo, Charles J ^a   Kern, Scott E ^a   Goggins, Michael ^a   Hruban, Ralph H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Gene Logic Inc   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

AFFYMETRIX GENECHIP HYBRIDIZATION; ARTICLE; CANCER CELL CULTURE; CELL LINE; CHRONIC DISEASE; CHRONIC PANCREATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DUODENUM MUCOSA; EXPRESSED SEQUENCE TAG; FASCIN GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HIGHLY EXPRESSED GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; INTESTINE MUCOSA; KALLIKREIN 10 GENE; MESOTHELIN GENE; METABOLISM; METHODOLOGY; MUC4 GENE; MUC5A GENE; MUC5C GENE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PANCREATIC DUCTAL ADENOCARCINOMA; PANCREATITIS; PHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SERIAL ANALYSIS OF GENE EXPRESSION; STATISTICAL ANALYSIS; STRATIFIN GENE; TMPRSS3 GENE; TRANSCRIPTION REGULATION; TRANSGLUTAMINASE 2 GENE; TUMOR CELL LINE; TUMOR CLASSIFICATION; VALIDATION PROCESS;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CHRONIC DISEASE; DATA INTERPRETATION, STATISTICAL; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PANCREATITIS; PRINCIPAL COMPONENT ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 9144241047     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., Gocayne, J. D., Amanatides. P., Ballew, R. M., Huson. D. H., Wortman, J. R., Zhang, Q., Kodira, C. D., Zheng, X. H., Chen, L., Skupski, M., Subramanian, G., Thomas, P. D., Zhang, J., Gabor Miklos, G. L., Nelson, C., Broder, S., Clark, A. G., Nadeau, J., McKusick, V. A., Zinder, N., Levine, A. J., Roberts, R. J., Simon, M., Slayman, C., Hunkapiller, M., Bolanos. R., Delcher, A., Dew, I., Fasulo, D., Flanigan, M., Florea, L., Halpern, A., Hannenhalli, S., Kravitz, S., Levy, S., Mobarry, C., Reinert, K., Remington, K., Abu-Threideh, J., Beasley, E., Biddick, K., Bonazzi, V., Brandon, R., Cargill, M., Chandramouliswaran, I., Charlab, R., Chaturvedi, K., Deng, Z., Di, F., V, Dunn, P., Eilbeck, K., Evangelista. C., Gabrielian, A. E., Gan, W., Ge, W., Gong, F., Gu, Z., Guan, P., Heiman, T. J., Higgins, M. E., Ji, R. R., Ke, Z., Ketchum, K. A., Lai, Z., Lei, Y., Li, Z., Li, J., Liang, Y., Lin, X., Lu, F., Merkulov, G. V., Milshina, N., Moore, H. M., Naik, A. K., Narayan, V. A., Neelam, B., Nusskern, D., Rusch, D. B., Salzberg, S., Shao, W., Shue, B., Sun, J., Wang, Z., Wang, A., Wang, X., Wang, J., Wei, M., Wides, R., Xiao, C., Yan, C., Yao, A., Ye, J., Zhan, M., Zhang, W., Zhang, H., Zhao, Q., Zheng, L., Zhong, F., Zhong, W., Zhu, S., Zhao, S., Gilbert, D., Baumhueter, S., Spier, G., Carter, C., Cravchik, A., Woodage, T., Ali, F., An, H., Awe, A., Baldwin, D., Baden, H., Barnstead, M., Barrow, I., Beeson, K., Busam, D., Carver, A., Center, A., Cheng, M. L., Curry, L., Danaher, S., Davenport, L., Desilets, R., Dietz, S., Dodson, K., Doup, L., Ferriera, S., Garg, N., Gluecksmann, A., Hart, B., Haynes, J., Haynes, C., Heiner, C., Hladun, S., Hostin, D., Houck, J., Howland, T., Ibegwam, C., Johnson, J., Kalush, F., Kline, L., Koduru, S., Love, A., Mann, F., May, D. McCawley, S., MeIntosh, T., McMullen, I., Moy, M., Moy, L., Murphy, B., Nelson, K., Pfannkoch, C., Pratts, E., Puri, V., Qureshi, H., Reardon, M., Rodriguez, R., Rogers, Y. H., Romblad, D., Ruhfel, B., Scott, R., Sitter, C., Smallwood, M., Stewart, E., Strong, R., Suh, E., Thomas, R., Tint, N. N., Tse, S., Vech, C., Wang, G., Wetter, J., Williams, S., Williams, M., Windsor, S., Winn-Deen, E., Wolfe, K., Zaveri, J., Zaveri, K., Abril, J. F., Guigo, R., Campbell, M. J., Sjolander, K. V., Karlak, B., Kejariwal, A., Mi, H., Lazareva, B., Hatton, T., Narechania, A., Diemer, K., Muruganujan, A., Guo, N., Sato, S., Bafna, V., Istrail, S., Lippert, R., Schwartz, R., Walenz, B., Yooseph, S., Allen, D., Basu, A., Baxendale, J., Blick, L., Caminha, M., Carnes-Stine, J., Caulk, P., Chiang, Y. H., Coyne, M., Dahlke, C., Mays, A., Dombroski, M., Donnelly, M., Ely, D., Esparham, S., Fosler, C., Gire, H., Glanowski, S., Glasser, K., Glodek, A., Gorokhov, M., Graham, K., Gropman, B., Harris, M., Heil, J., Henderson, S., Hoover, J., Jennings, D., Jordan, C., Jordan, J., Kasha, J., Kagan, L., Kraft, C., Levitsky, A., Lewis, M., Liu, X., Lopez, J., Ma, D., Majoros, W., McDaniel, J., Murphy, S., Newman, M., Nguyen, T., Nguyen, N., and Nodell, M. The sequence of the human genome. Science, 291: 1304-1351, 2001.
2. Olivier, M., Aggarwal, A., Allen, J., Almendras, A. A., Bajorek, E. S., Beasley, E. M., Brady, S. D., Bushard, J. M., Bustos, V. I., Chu, A., Chung, T. R., De Witte, A., Denys, M. E., Dominguez, R., Fang, N. Y., Foster, B. D., Freudenberg, R. W., Hadley, D., Hamilton, L. R., Jeffrey, T. J., Kelly, L., Lazzeroni, L., Levy, M. R., Lewis, S. C., Liu, X., Lopez, F. J., Louie, B., Marquis, J. P., Martinez, R. A., Matsuura, M. K., Misherghi, N. S., Norton, J. A., Olshen, A., Perkins, S. M., Perou, A. J., Piercy, C., Piercy, M., Qin, F., Reif, T., Sheppard, K., Shokoohi, V., Smick, G. A., Sun, W. L., Stewart, E. A., Fernando, J., Tejeda, Tran, N. M., Trejo, T., Vo, N. T., Yan, S. C., Zierten, D. L., Zhao, S., Sachidanandam, R., Trask, B. J., Myers, R. M., and Cox, D. R. A high-resolution radiation hybrid map of the human genome draft sequence. Science, 291: 1298-1302, 2001.
3. Wallrapp, C., and Gress, T. M. Isolation of differentially expressed genes by representational difference analysis. Methods Mol. Biol., 175: 279-294, 2001.
4. Gress, T. M., Wallrapp, C., Frohme, M., Muller-Pillasch, F., Lacher, U., Friess, H., Buchler, M., Adler, G., and Hoheisel. J. D. Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis. Genes Chromosomes Cancer, 19: 97-103, 1997.
5. Paciucci, R., Berrozpe, G., Tora, M., Navarro, E., Garcia, d. H., and Real, F. X. Isolation of tissue-type plasminogen activator, cathepsin H, and non-specific crossreacting antigen from SK-PC-1 pancreas cancer cells using subtractive hybridization. FEBS Lett., 385: 72-76, 1996.
6. Gardner-Thorpe, J., Ito, H., Ashley, S. W., and Whang, E. E. Differential display of expressed genes in pancreatic cancer cells. Biochem. Biophys. Res Commun., 293: 391-395, 2002.
7. Ryu, B., Jones. J., Blades, N. J., Parmigiani, G., Hollingsworth, M. A., Hruban, R. H., and Kern, S. E. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res., 62: 819-826, 2002.
8. Argani, P., Rosty, C., Reiter, R. E., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Ryu, B., Skinner, H. G., Goggins, M., Jaffee, E. M., Yeo, C. J., Cameron, J. L., Kern, S. E., and Hruban. R. H. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res., 61: 4320-4324, 2001.
9. Argani, P., Iacobuzio-Donahue, C., Ryu, B., Rosty, C., Goggins, M., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Jaffee, E., Yeo, C. J., Cameron, J. L., Kem, S. E., and Hruban. R. H. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin. Cancer Res., 7: 3862-3868, 2001.
10. Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., Lowe, A. W., Van Heek, N. T., Rosty, C., Walter, K., Sato, N., Parker, A., Ashfaq, R., Jaffee, E., Ryu, B., Jones, J., Eshleman, J. R., Yeo, C. J., Cameron, J. L., Kem, S. E., Hruban, R. H., Brown, P. O., and Goggins, M. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol., 162: 1151-1162, 2003.
11. Han, H., Bearss, D. J., Browne, L. W., Calaluce, R., Nagle, R. B., and Von Hoff, D. D. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res., 62: 2890-2896, 2002.
12. Crnogorac-Jurcevic, T., Efthimiou, E., Nielsen, T., Loader, J., Terris, B., Stamp, G., Baron, A., Scarpa, A., and Lemoine, N. R. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene, 21: 4587-4594, 2002.
13. Crnogorac-Jurcevic, T., Missiaglia, E., Blaveri, E., Gangeswaran, R., Jones, M., Terris, B., Costello, E., Neoptolemos, J. P., and Lemoine, N. R. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S 100 genes is highly prevalent. J. Pathol., 201: 63-74, 2003.
14. Iacobuzio-Donahue, C. A., Maitra. A., Shen-Ong, G. L., van Heek, T., Ashfaq, R., Meyer, R., Walter, K., Berg, K., Hollingsworth, M. A., Cameron, J. L., Yeo, C. J., Kem, S. E., Goggins, M., and Hruban, R. H. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol, 160: 1239-1249, 2002.
15. Jaffee, E. M., Hruban, R. H., Biedrzycki, B., Laheru, D., Schepers, K., Sauter, P. R., Goemann, M., Coleman, J., Grochow, L., Donehower. R. C., Lillemoe, K. D., O'Reilly, S., Abrams, R. A., Pardoll, D. M., Cameron, J. L., and Yeo, C. J. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a Phase 1 trial of safety and immune activation. J. Clin. Oncol., 19: 145-156, 2001.
16. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
17. Kolar, C., Caffrey, T., Hollingsworth, M., Scheetz, M., Sutherlin, M., Weide, L., and Lawson, T. Duct epithelial cells cultured from human pancreas processed for transplantation retain differentiated ductal characteristics. Pancreas, 15: 265-271, 1997.
18. Maitra, A., Iacobuzio-Donahue, C., Rahman, A., Sohn, T. A., Argani, P., Meyer, R., Yeo, C. J., Cameron, J. L., Goggins, M., Kem, S. E., Ashfaq, R., Hruban, R. H., and Wilentz, R. E. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocaminoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am. J. Clin. Pathol., 118: 52-59, 2002.
19. Iacobuzio-Donahue, C. A., Ryu, B., Hruban, R. H., and Kern, S. E. Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplasdc cells at the site of primary invasion. Am. J. Pathol., 160: 91-99, 2002.
20. Iacobuzio-Donahue, C. A., Argani Pedram, Hempen, P., Jones, J., and Kern, S. E. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion with implications for comparisons between tumor types. Cancer Res., 62: 5351-5357, 2002.
21. Swartz, M. J., Batra, S. K., Varshney, G. C., Hollingsworth, M. A., Yeo, C. J., Cameron, J. L., Wilentz, R. E., Hruban, R. H., and Argani, P. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am. J. Clin. Pathol., 117: 791-796, 2002.
22. Balague, C., Gambus, G., Carrato, C., Porchet, N., Aubert, J. P., Kim, Y. S., and Real, F. X. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology. 106: 1054-1061, 1994.
23. Richardson, D. R. The role of the membrane-bound tumour antigen, melanotrans-ferrin (p97), in iron uptake by the human malignant melanoma cell. Eur. J. Biochem., 267: 1290-1298, 2000.
24. Wu, Q., and Maniatis, T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell. 97: 779-790, 1999.
25. Santamaria, I., Velasco, G., Cazorla, M., Fueyo, A., Campo, E., and Lopez-Otin, C. Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res., 58: 1624-1630, 1998.
26. Luo, L. Y., Katsaros, D., Scorilas, A., Fracchioli, S., Bellino, R., van Gramberen, M., de Bruijn, H., Henrik, A., Stenman, U. H., Massobrio, M., van der Zee, A. G., Vergote, I., and Diamandis, E. P. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res., 63: 807-811, 2003.
27. Petraki, C. D., Karavana, V. N., Luo, L. Y., and Diamandis, E. P. Human kallikrein 10 expression in normal tissues by immanohistochemistry. J. Histochem. Cytochem., 50: 1247-1261, 2002.
28. Klatt, A. R., Nitsche, D. P., Kobbe, B., Morgelin, M., Paulsson, M., and Wagener, R. Molecular structure and tissue distribution of matrilin-3, a filament-forming extracellular matrix protein expressed during skeletal development. J. Biol. Chem., 275: 3999-4006, 2000.
29. Kerr, D. E., Vrudhula, V. M., Svensson, H. P., Siemers, N. O., and Senter, P. D. Comparison of recombinant and synthetically formed monoclonal antibody-β-lactamase conjugates for anticancer prodrug activation. Bioconjug. Chem., 10: 1084-1089, 1999.
30. Hassan, R., Viner, J. L., Wang, Q. C., Margulies, I., Kreitman, R. J., and Pastan, I. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. J. Immunother., 23: 473-479, 2000.
31. Saffran, D. C., Raitano, A. B., Hubert, R. S., Witte, O. N., Reiter, R. E., and Jakobovits, A. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc. Natl. Acad. Sci. USA, 98: 2658-2663, 2001.
32. Ross, S., Spencer, S. D., Strickland, L., Lasky, L. A., and Koeppen, H. Prostate stem cell antigen (PSCA) is a potential therapy target for pancreatic cancer. U. S. Cancer Acad. Pathol., 2002.
33. Wallrapp, C., Hahnel, S., Muller-Pillasch, F., Burghardt, B., Iwamura, T., Ruthenburger, M., Lerch, M. M., Adler, G., and Gress, T. M. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res., 60: 2602-2606, 2000.
34. Linnenbach, A. J., Wojcierowski, J., Wu, S. A., Pyrc, J. J., Ross, A. H., Dietzschold, B., Speicher, D., and Koprowski, H. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family. GA733. Proc. Natl. Acad. Sci. USA, 86: 27-31, 1989.
35. Furutani, M., Arii, S., Mizumoto, M., Kato, M., and Imamura, M. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett., 122: 209-214, 1998.
36. Michl, P., Buchholz, M., Rolke, M., Kunsch, S., Lohr, M., McClane, B., Tsukita, S., Leder, G., Adler, G., and Gress, T. M. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology, 121: 678-684, 2001.
37. Real, F. X., Villa, M. R., Skoudy, A., Ramaekers, F. C. S., and Corominas, J. M. Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer. Int. J. Cancer. 54: 720-727, 1993.
38. Sinha, P., Hutter, G., Kottgen, E., Dietel, M., Schadendorf, D., and Lage, H. Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-σ (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis, 20: 2952-2960, 1999.
39. Elsasser, H. P., MacDonald, R., Dienst, M., and Kern, H. F. Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells. Eur. J. Cell Biol., 61: 321-328, 1993.
40. Maitra, A., Adsay, N. V., Argani, P., Iacobuzio-Donahue, C., De Marzo, A., Cameron, J. L., Yeo, C. J., and Hruban, R. H. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod. Pathol., 16: 902-912, 2003.
41. Tersmette, A. C., Petersen, G. M., Offerhaus, G. J., Falatko, F. C., Brune, K. A., Goggins, M., Rozenblum, E., Wilentz, R. E., Yeo, C. J., Cameron, J. L., Kern, S. E., and Hruban, R. H. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin. Cancer Res., 7: 738-744, 2001.
42. Joo, Y. E., Rew, J. S., Park, C. S., and Kim, S. J. Expression of E-cadherin, α- and β-catenins in patients with pancreatic adenocarcinoma. Pancreatology, 2: 129-137, 2002.
43. Yamaguchi, N., Chung, S. M., Shiroeda, O., Koyama, K., and Imanishi, J. Characterization of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP. Cancer Res., 50: 658-663, 1990.
44. 2-M modulators in pancreatic adenocarcinoma. Pancreatology, 2: 138-145, 2002.
45. Yang, T., and Chen, J. Y. Identification and cellular localization of human PFRAIREI. Gene (Amst.), 267: 165-172, 2001.
46. Poch, B., Gansauge, F., Schwarz, A., Seufferlein, T., Schnelldorfer, T., Ramadani, M., Beger, H. G., and Gansauge, S. Epidermal growth factor induces cyclin DI in human pancreatic carcinoma: evidence for a Cyclin D1-dependent cell cycle progression. Pancreas, 23: 280-287, 2001.
47. Zhu, Z., Kleeff, J., Friess, H., Wang, L., Zimmermann, A., Yarden, Y., Buchler, M. W., and Korc, M. Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. Biochem. Biophys. Res. Commun., 273: 1019-1024, 2000.
48. Kleeff, J., Ishiwata, T., Friess, H., Buchler, M. W., and Korc, M. Concomitant over-expression of activin/inhibin β subunits and their receptor in human pancreatic cancer. Int. J. Cancer, 77: 860-868, 1998.
49. Shi, Q., Abbruzzese, J. L., Huang, S., Fidler, I. J., Xiong, Q., and Xie, K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin. Cancer Res., 5: 3711-3721, 1999.
50. Goldstein, N. S., and Bassi, D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Am. J. Clin. Pathol., 115: 695-702, 2001.
51. Berberat, P. O., Friess, H., Wang, L., Zhu, Z., Bley, T., Frigeri, L., Zimmermann, A., and Buchler, M. W. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J. Histochem. Cytochem., 49: 539-549, 2001.
52. von Marschall, Z., Riecken, E. O., and Rosewicz, S. Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines. Gut, 43: 692-698, 1998.
53. Yamamoto, H., Itoh, F., Iku, S., Adachi, Y., Fukushima, H., Sasaki, S., Mukaiya, M., Hirata, K., and Imai, K. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas clinicopathologic and prognostic significance of matrilysin expression. J. Clin. Oncol., 19: 1118-1127, 2001.
54. Tomioka, D., Maehara, N., Kuba, K., Mizumoto, K., Tanaka, M., Matsumoto, K., and Nakamura, T. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Res., 61: 7518-7524, 2001.
55. Ellenrieder, V., Hendler, S. F., Ruhland, C., Boeck, W., Adler, G., and Gress, T. M. TGF-β-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int. J. Cancer, 93: 204-211, 2001.
56. Paciucci, R., Vila, M. R., Adell, T., Diaz, V. M., Tora, M., Nakamura, T., and Real, F. X. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met. Am. J. Pathol., 153: 201-212, 1998.
57. Rosty, C., Ueki, T., Argani, P., Jansen, M., Yeo, C. J., Cameron, J. L., Hruban, R. H., and Goggins, M. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am. J. Pathol., 160: 45-50, 2002.
58. Zhang, J. S., Wang, L., Huang, H., Nelson, M., and Smith, D. I. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells. Genes Chromosomes Cancer, 30: 123-135, 2001.
59. Ohnami, S., Matsumoto, N., Nakano, M., Aoki, K., Nagasaki, K., Sugimura, T., Terada, M., and Yoshida, T. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity. Cancer Res., 59: 5565-5571, 1999.
60. and Hruban, R. H. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin. Cancer Res., 7: 738-744, 2001.